b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">\n        <PMID Version="1">31933896</PMID>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>03</Month>\n            <Day>25</Day>\n        </DateRevised>\n        <Article PubModel="Electronic-eCollection">\n            <Journal>\n                <ISSN IssnType="Electronic">1936-2625</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>12</Volume>\n                    <Issue>3</Issue>\n                    <PubDate>\n                        <Year>2019</Year>\n                    </PubDate>\n                </JournalIssue>\n                <Title>International journal of clinical and experimental pathology</Title>\n                <ISOAbbreviation>Int J Clin Exp Pathol</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Expression of PD-L1 in mononuclear cells, multinucleated cells, and foam cells in tenosynovial giant cell tumors.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>876-884</MedlinePgn>\n            </Pagination>\n            <Abstract>\n                <AbstractText>Tenosynovial giant cell tumor (TGCT) is a rare, proliferative and inflammatory disease with activation of colony stimulating factor 1 (CSF1) expression, and exhibits abnormal proliferation of mononuclear cells, multinucleated cells and foam cells. PD-L1 inhibitors represent a promising strategy in a variety of tumors. However, PD-L1 expression has never been studied in CSF1 activated TGCT. In this study, we determined the expression of programmed cell death ligand 1 (PD-L1) in 40 TGCT cases by immunohistochemistry and evaluated its clinical significance. We found that PD-L1 was positively expressed in 52.5% of all patients, and among them, the mononuclear cells, multinucleated cells, and foam cells with positive PD-L1 expression were observed in 21 (52.5%), 10 (25.0%), and 7 (17.5%) patients, respectively. The mononuclear cells and foam cells exhibited PD-L1 expression on the membrane or in the cytoplasm, and the multinucleated cells showed membranous PD-L1 expression. In addition, the PD-L1-positive mononuclear cells, multinucleated cells, and foam cells co-expressed CD68. Moreover, the patients with positive PD-L1 expression had a larger tumor size than those with negative PD-L1 expression. We further found that the foam cells of human coronary atherosclerosis also exhibited the expression of PD-L1 in two of three patients. These findings provide valuable evidence that PD-L1 is highly positive in CSF1-activated TGCT, and treatment with anti-PD-L1 agents may be a valuable therapeutic option for those diseases with PD-L1 expression on mononuclear cells, multinucleated cells, or foam cells.</AbstractText>\n                <CopyrightInformation>IJCEP Copyright \xc2\xa9 2019.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Zheng</LastName>\n                    <ForeName>Biqiang</ForeName>\n                    <Initials>B</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Musculoskeletal Cancer Surgery, Fudan University Shanghai Cancer Center Shanghai, China.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Oncology, Shangai Medical College, Fudan University Shanghai, China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Yu</LastName>\n                    <ForeName>Lin</ForeName>\n                    <Initials>L</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pathology, Fudan University Shanghai Cancer Center Shanghai, China.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Oncology, Shangai Medical College, Fudan University Shanghai, China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Hu</LastName>\n                    <ForeName>Jingying</ForeName>\n                    <Initials>J</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine Shanghai, China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Xu</LastName>\n                    <ForeName>Huili</ForeName>\n                    <Initials>H</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine Shanghai, China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Wang</LastName>\n                    <ForeName>Jian</ForeName>\n                    <Initials>J</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pathology, Fudan University Shanghai Cancer Center Shanghai, China.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Oncology, Shangai Medical College, Fudan University Shanghai, China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Shi</LastName>\n                    <ForeName>Yingqiang</ForeName>\n                    <Initials>Y</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Musculoskeletal Cancer Surgery, Fudan University Shanghai Cancer Center Shanghai, China.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Oncology, Shangai Medical College, Fudan University Shanghai, China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Luo</LastName>\n                    <ForeName>Xiaoying</ForeName>\n                    <Initials>X</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine Shanghai, China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Yan</LastName>\n                    <ForeName>Wangjun</ForeName>\n                    <Initials>W</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Musculoskeletal Cancer Surgery, Fudan University Shanghai Cancer Center Shanghai, China.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Oncology, Shangai Medical College, Fudan University Shanghai, China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2019</Year>\n                <Month>03</Month>\n                <Day>01</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>United States</Country>\n            <MedlineTA>Int J Clin Exp Pathol</MedlineTA>\n            <NlmUniqueID>101480565</NlmUniqueID>\n            <ISSNLinking>1936-2625</ISSNLinking>\n        </MedlineJournalInfo>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">PD-L1</Keyword>\n            <Keyword MajorTopicYN="N">TGCT</Keyword>\n            <Keyword MajorTopicYN="N">foam cells</Keyword>\n            <Keyword MajorTopicYN="N">mononuclear cells</Keyword>\n            <Keyword MajorTopicYN="N">multinucleated giant cells</Keyword>\n        </KeywordList>\n        <CoiStatement>None.</CoiStatement>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2018</Year>\n                <Month>12</Month>\n                <Day>22</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2019</Year>\n                <Month>01</Month>\n                <Day>24</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2020</Year>\n                <Month>1</Month>\n                <Day>15</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2020</Year>\n                <Month>1</Month>\n                <Day>15</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2020</Year>\n                <Month>1</Month>\n                <Day>15</Day>\n                <Hour>6</Hour>\n                <Minute>1</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>epublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">31933896</ArticleId>\n            <ArticleId IdType="pmc">PMC6945150</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>Hum Pathol. 2003 Jan;34(1):65-73</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12605368</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Am J Surg Pathol. 2007 Jun;31(6):970-6</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17527089</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Sci Transl Med. 2012 Mar 28;4(127):127ra37</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22461641</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lab Invest. 2014 Apr;94(4):371-81</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24468794</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lancet Oncol. 2015 Aug;16(8):949-56</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26179200</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Immunol Res. 2017 Mar;5(3):248-256</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28148545</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Res. 2016 May 1;76(9):2552-60</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27013192</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nature. 2014 Nov 27;515(7528):558-62</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25428503</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Sci. 2013 Apr;104(4):516-23</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23347208</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nature. 2017 May 25;545(7655):495-499</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28514441</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Orthop Sci. 2004;9(6):581-4</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16228675</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Immunol Immunother. 2007 Aug;56(8):1173-82</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17186290</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Exp Med. 2001 Mar 19;193(6):727-40</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">11257139</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Blood. 2016 Sep 22;128(12):1590-603</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27418644</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Cancer Res. 2007 Apr 1;13(7):2151-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17404099</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Onco Targets Ther. 2016 Aug 12;9:5023-39</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27574444</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Immunother Cancer. 2017 Jul 18;5(1):53</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28716061</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Cell. 2013 Feb 11;23(2):249-62</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23410977</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Proc Natl Acad Sci U S A. 2006 Jan 17;103(3):690-5</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16407111</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Sci. 2008 Aug;99(8):1595-602</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18754872</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Eur J Cancer. 2014 May;50(7):1361-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24548766</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mod Pathol. 1995 Feb;8(2):155-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">7777476</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Mol Med (Berl). 2017 Nov;95(11):1153-1165</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28785870</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Invest. 2017 Jun 30;127(7):2725-2738</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28604383</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3360-5</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17360651</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncogene. 2014 Jul 17;33(29):3812-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23995783</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>N Engl J Med. 2015 Jul 30;373(5):428-37</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26222558</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Am J Pathol. 1997 Apr;150(4):1383-93</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">9094994</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Exp Hematol. 1991 Nov;19(10):1049-54</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">1915705</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncol Rep. 2000 Mar-Apr;7(2):413-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">10671695</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncoimmunology. 2017 Feb 21;6(4):e1294299</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28507803</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Oncol. 2016 Nov;49(5):2064-2074</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27599777</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncogene. 2012 Mar 15;31(11):1459-67</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21822305</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Biol Ther. 2008 May;7(5):622-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18756622</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'